Canada Life’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Buy |
981
+76
| +8% | +$5.35K | ﹤0.01% | 1808 |
|
|
2025
Q1 | $67K | Buy |
905
+163
| +22% | +$12.1K | ﹤0.01% | 1830 |
|
|
2024
Q4 | $49K | Sell |
742
-305
| -29% | -$20.1K | ﹤0.01% | 1893 |
|
|
2024
Q3 | $82K | Buy |
1,047
+258
| +33% | +$20.2K | ﹤0.01% | 1890 |
|
|
2024
Q2 | $62K | Buy |
789
+283
| +56% | +$22.2K | ﹤0.01% | 1946 |
|
|
2024
Q1 | $34K | Buy |
506
+146
| +41% | +$9.81K | ﹤0.01% | 2047 |
|
|
2023
Q4 | $24K | Sell |
360
-700
| -66% | -$46.7K | ﹤0.01% | 2085 |
|
|
2023
Q3 | $72K | Buy |
1,060
+530
| +100% | +$36K | ﹤0.01% | 2027 |
|
|
2023
Q2 | $38K | Sell |
530
-1,819
| -77% | -$130K | ﹤0.01% | 2034 |
|
|
2023
Q1 | $163K | Buy |
2,349
+957
| +69% | +$66.4K | ﹤0.01% | 1899 |
|
|
2022
Q4 | $94K | Buy |
1,392
+348
| +33% | +$23.5K | ﹤0.01% | 1997 |
|
|
2022
Q3 | $57K | Buy |
1,044
+268
| +35% | +$14.6K | ﹤0.01% | 2076 |
|
|
2022
Q2 | $51K | Buy |
776
+251
| +48% | +$16.5K | ﹤0.01% | 2055 |
|
|
2022
Q1 | $36K | Buy |
525
+266
| +103% | +$18.2K | ﹤0.01% | 2234 |
|
|
2021
Q4 | $15K | Sell |
259
-336,199
| -100% | -$19.5M | ﹤0.01% | 2416 |
|
|
2021
Q3 | $20.3M | Buy |
+336,458
| New | +$20.3M | 0.05% | 393 |
|
|
2017
Q4 | – | Sell |
-316,751
| Closed | -$10.7M | – | 2548 |
|
|
2017
Q3 | $10.7M | Buy |
+316,751
| New | +$10.7M | 0.03% | 502 |
|
|
2015
Q3 | – | Sell |
-34,872
| Closed | -$1.11M | – | 2450 |
|
|
2015
Q2 | $1.11M | Buy |
34,872
+16
| +0% | +$509 | ﹤0.01% | 903 |
|
|
2015
Q1 | $1.19M | Sell |
34,856
-474
| -1% | -$16.2K | ﹤0.01% | 889 |
|
|
2014
Q4 | $1.25M | Buy |
35,330
+8,600
| +32% | +$303K | ﹤0.01% | 870 |
|
|
2014
Q3 | $955K | Buy |
26,730
+10,600
| +66% | +$379K | ﹤0.01% | 896 |
|
|
2014
Q2 | $598K | Hold |
16,130
| – | – | ﹤0.01% | 902 |
|
|
2014
Q1 | $521K | Buy |
+16,130
| New | +$521K | ﹤0.01% | 906 |
|